Transatlantique Private Wealth LLC Cuts Stake in Zoetis Inc. (NYSE:ZTS)

Transatlantique Private Wealth LLC lessened its stake in Zoetis Inc. (NYSE:ZTS) by 2.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,046 shares of the company’s stock after selling 196 shares during the quarter. Transatlantique Private Wealth LLC’s holdings in Zoetis were worth $1,220,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of the stock. Aveo Capital Partners LLC bought a new position in shares of Zoetis in the fourth quarter worth approximately $225,000. Gryphon Financial Partners LLC lifted its position in Zoetis by 11.8% in the 4th quarter. Gryphon Financial Partners LLC now owns 3,056 shares of the company’s stock valued at $601,000 after acquiring an additional 322 shares in the last quarter. Jump Financial LLC purchased a new stake in Zoetis during the 4th quarter valued at $339,000. TrinityPoint Wealth LLC increased its holdings in shares of Zoetis by 0.3% in the 4th quarter. TrinityPoint Wealth LLC now owns 22,319 shares of the company’s stock worth $4,405,000 after purchasing an additional 73 shares in the last quarter. Finally, Franklin Resources Inc. increased its holdings in shares of Zoetis by 8.9% in the 4th quarter. Franklin Resources Inc. now owns 161,489 shares of the company’s stock worth $31,873,000 after purchasing an additional 13,236 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on ZTS shares. Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Stifel Nicolaus raised their price target on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday. Piper Sandler lifted their price target on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Finally, BTIG Research increased their price objective on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Nine analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $220.38.

Zoetis Stock Performance

Shares of NYSE ZTS opened at $192.73 on Friday. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The firm has a market capitalization of $87.94 billion, a price-to-earnings ratio of 37.13, a price-to-earnings-growth ratio of 2.98 and a beta of 0.88. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. The firm has a 50 day moving average of $184.70 and a 200 day moving average of $174.47.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.07. The business had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The company’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.41 earnings per share. On average, research analysts anticipate that Zoetis Inc. will post 5.84 earnings per share for the current year.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.